Q98443451

Summary

Q98443451 is an interpellation^[1].

Key Facts

• Q98443451 authored Ana Maria Narti^[2].
• Q98443451's instance of is recorded as interpellation^[3].
• Q98443451's part of the series is recorded as interpellations of the 2003/04 legislative session of the Riksdag^[4].
• Q98443451's language of work or name is recorded as Swedish^[5].
• Q98443451's publication date is recorded as +2004-04-01T00:00:00Z^[6].
• Q98443451's significant event is recorded as debate^[7].
• Q98443451's main subject is recorded as medication^[8].
• Q98443451's work available at URL is recorded as http://data.riksdagen.se/dokument/GR10405^[9].
• Q98443451's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/GR10405^[10].
• Q98443451's applies to jurisdiction is recorded as Sweden^[11].
• Q98443451's legal citation of this text is recorded as ip. 2003/04:405^[12].
• Q98443451's title is recorded as läkemedel och vårdens kvalitet^[13].
• Q98443451's addressee is recorded as Lars Engqvist^[14].
• Q98443451's maintained by WikiProject is recorded as Project Riksdagen's documents^[15].
• Q98443451's copyright status is recorded as public domain^[16].
• Q98443451's Swedish Riksdag document ID is recorded as GR10405^[17].

Body

Works and Contributions

Q98443451 authored Ana Maria Narti^[2].